Transaction #4656 · Form 4 · 0001493152-25-020753
Akari Therapeutics Plc · Stock award · American Depositary Shares representing Ordinary Shares
Akari Therapeutics Plc · Transacted November 1, 2025 · Filed November 4, 2025
What does this filing report?
An SEC Form 4 filing for Akari Therapeutics Plc records a stock award involving American Depositary Shares representing Ordinary Shares on November 1, 2025. The reported quantity was 26,619. The filing date is November 4, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Akari Therapeutics Plc
- Company CIK
- 0001541157
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 26,619
- Reported price
- 0.75
- Reference value
- 19,964.25
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 26,619
- Ownership description
- Not reported
- SEC acceptance time
- Nov 4, 2025, 5:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Farag Kameel D. ↗
Interim CFO
CIK 0002093620
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer
- F2
- These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026.
- F3
- These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on February 15, 2026.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.